Derek Hainy

Derek Hainy

Healthcare Regulation Expert
Derek Hainy is a public policy expert specializing in healthcare regulation. He provides insightful analysis of the latest regulatory changes affecting healthcare providers. Focusing on compliance, Derek helps medical professionals navigate healthcare laws, requirements, and reforms. He also covers the future of healthcare data privacy regulations and the regulatory landscape for telehealth services. 
How Did SMC Telogorejo Revolutionize Patient Care with Tech?
Public Policy How Did SMC Telogorejo Revolutionize Patient Care with Tech?

I'm thrilled to sit down with Faisal Zain, a renowned expert in healthcare technology with a deep background in medical device manufacturing for diagnostics and treatment. With years of experience driving innovation, Faisal has a unique perspective on how digital transformation is reshaping

Can Arkansas Law Curb Big Pharmacy Benefit Managers?
Public Policy Can Arkansas Law Curb Big Pharmacy Benefit Managers?

Setting the Stage: A Tug-of-War in Healthcare Markets In the complex landscape of American healthcare, a fierce battle is unfolding over the unchecked power of pharmacy benefit managers (PBMs), intermediaries that dictate prescription drug pricing and access for millions of people across the

Medicare and Medicaid: 60 Years of Transforming Healthcare
Public Policy Medicare and Medicaid: 60 Years of Transforming Healthcare

Introduction The establishment of Medicare and Medicaid in 1965 marked a turning point in American healthcare, addressing long-standing inequities by providing health insurance to older adults, individuals with disabilities, and low-income populations. Signed into law under President Lyndon B.

Trend Analysis: Trump's Healthcare Legislation Impact
Public Policy Trend Analysis: Trump's Healthcare Legislation Impact

Health insurance premiums in the United States have become a focal point in recent years. With President Donald Trump's One Big Beautiful Bill Act (OBBBA) impacting the healthcare landscape, middle-class Americans are bracing for significant changes to their healthcare costs. Understanding

Siemens Unveils MRI Scanner Revolutionizing Radiology and Veterinary Care
Public Policy Siemens Unveils MRI Scanner Revolutionizing Radiology and Veterinary Care

The radiology and veterinary care industry operates at the intersection of cutting-edge technology and essential healthcare services, continuously evolving to meet diverse demands. Currently, this sector includes significant market segments such as diagnostic imaging, veterinary radiology, and

Is Safety Endangered in Gene Therapy Trials?
Public Policy Is Safety Endangered in Gene Therapy Trials?

The gene therapy industry is at a crucial juncture, with recent events prompting intense scrutiny over patient safety in clinical trials. The halt of Sarepta Therapeutics' trials by the U.S. Food and Drug Administration (FDA) serves as a stark reminder of the inherent risks associated with

Biopharma Faces Regulatory Shift: FDA, Trials, and Mergers
Public Policy Biopharma Faces Regulatory Shift: FDA, Trials, and Mergers

The biopharmaceutical sector is currently experiencing a dynamic phase marked by regulatory reforms, technological growth, and strategic corporate actions. This environment presents both challenges and opportunities for industry players, prompting adaptive strategies to thrive in an evolving

Debunking Myths About Nondisabled Medicaid Recipients
Public Policy Debunking Myths About Nondisabled Medicaid Recipients

Amid ongoing debates about Medicaid's role in providing for nondisabled adults, misconceptions surrounding these beneficiaries continue to garner attention. With some narratives painting these individuals as choosing leisure over productivity, it becomes essential to dissect the realities

Congress Urged to Protect Medicare and Medicaid Funding
Public Policy Congress Urged to Protect Medicare and Medicaid Funding

Today, we're privileged to have Faisal Zain, a pioneering healthcare expert renowned for his contributions to the field of medical technology and manufacturing of diagnostic devices. With his extensive experience, Mr. Zain has been at the forefront of innovation, driving progress in medical

FDA Approves Lenacapavir: A Twice-Yearly HIV Prevention Breakthrough
Public Policy FDA Approves Lenacapavir: A Twice-Yearly HIV Prevention Breakthrough

Lenacapavir has recently been approved by the FDA as a twice-yearly injection, marking a significant milestone in the efforts toward global HIV prevention. This innovative treatment developed by Gilead Sciences, branded as Yetzugo, promises to revolutionize the landscape of HIV prevention efforts

Loading
Latest Articles

Subscribe to our weekly news digest

Keep up to date with the latest news and events

Paperplanes Paperplanes Paperplanes
Invalid Email Address
Thanks for Subscribing!
We'll be sending you our best soon!
Something went wrong, please try again later